First-in-human gene therapy trial for major cardiac syndrome
The US Food & Drug Administration (FDA) has approved the first-in-human gene therapy trial for heart failure patients with preserved ejection fraction.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
